APTO

Aptose Biosciences, Inc.
APTO

Overview Fund Activity
Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

20 hedge funds and large institutions have $2.06M invested in Aptose Biosciences, Inc. in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-4
Holders Change %
-16.67%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$1.3M
2
SPC
2
Sigma Planning Corp
Michigan
$178K
3
OP
3
ORG Partners
Indiana
$2.98K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$2K
5
TWC
5
TD Waterhouse Canada
Ontario, Canada
$5.65K

Top Sellers

1
AC
1
Annandale Capital
Texas
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
NCM
3
Nantahala Capital Management
Connecticut
$58.7K
4
Morgan Stanley
4
Morgan Stanley
New York
$23K
5
Cetera Investment Advisers
5
Cetera Investment Advisers
Illinois
$14.6K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$42.6K -856 Closed
BHWM
27
Beaird Harris Wealth Management
Texas
– -$415 -8 Closed
Wells Fargo
28
Wells Fargo
California
– -$120 -2 Closed
Bank of America
29
Bank of America
North Carolina
– -$110 -2 Closed
1
2